1. Malaysia Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Supermax Corporation Berhad

Supermax Corporation Berhad

SPMXF
Supermax Corporation BerhadUS flagOther OTC
0.15
USD
- -
- -
458.59MMarket Cap
Supermax Corporation Berhad
SPMXF
(Other OTC)

Recent

price

0.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.29
0.29
0.29
0.3
0.29
0.3
- -
0.33
0.39
0.46
0.64
2.21
0.85
0.26
0.21
- -
0.24
Revenue per Share
0.05
0.03
0.03
0.03
0.03
0.04
- -
0.02
0.03
0.04
0.16
1.18
0.23
-0.04
-0.06
- -
-0.09
Basic EPS, GAAP
- -
0.01
0.03
0.01
-0.01
-0.01
- -
- -
0.03
0.04
0.34
0.98
-0.03
-0.22
-0.25
- -
-0.05
Free Cash Flow per Basic Share
0.01
0.01
- -
0.01
0.01
0.01
- -
0.01
0.02
0.01
- -
0.14
0.21
0.04
0.03
- -
- -
Dividend per Share
0.18
0.2
0.25
0.27
0.29
0.32
- -
0.33
0.35
0.38
0.54
1.56
1.57
1.48
1.46
- -
0.11
Book Value per Share
0.19
0.21
0.23
0.25
0.26
0.29
- -
0.3
0.29
0.33
0.46
1.51
1.59
1.48
1.43
- -
1.24
Tangible Book Value per Share
3,411
3,502
3,497
3,496
3,496
3,502
1,348
3,450
3,384
3,323
3,313
3,245
3,173
3,164
3,118
- -
3,085
Basic Weighted Avg Shares
977
1,021
997
1,048
1,004
1,053
- -
1,127
1,304
1,538
2,132
7,164
2,687
821
646
782
751
Sales/Revenue/Turnover
15.91
8.79
12.3
13.26
12.61
13.93
- -
9.56
13.02
12.13
32.46
70
42.43
-17.28
-37.38
-32.15
-45.88
Operating Margin (%)
26
24
24
27
28
- -
- -
41
42
45
62
69
74
85
68
- -
- -
Depreciation Expense
159
104
122
120
96
127
- -
67
107
123
525
3,817
719
-141
-176
-160
-284
Net Income, GAAP
13.53
7.21
11.58
19.69
25.8
17.07
- -
34.88
31.97
28.6
21.38
21.71
28.54
- -
- -
- -
- -
Effective Tax Rate (%)
16.26
10.2
12.2
11.42
9.52
12.06
- -
5.96
8.18
8
24.62
53.27
26.75
-17.16
-27.18
-20.51
-37.78
Profit Margin (%)
225
263
278
275
214
154
- -
68
6
34
407
3,285
3,180
2,259
1,613
1,008
765
Working Capital
141
140
115
127
146
99
- -
107
62
61
102
64
53
19
22
14
17
LT Debt
692
769
834
898
944
1,036
- -
1,070
1,023
1,134
1,551
4,894
5,032
4,692
4,467
4,093
3,823
Total Equity
14.47
7.97
9.79
9.52
7.43
8.77
- -
9.17
7.72
8.76
30.2
96.16
13.94
- -
- -
- -
- -
Return on Invested Capital (%)
25.51
11.98
11.9
10.42
7.75
9.22
- -
8.99
7.02
8.32
27.82
97.73
12.63
- -
- -
- -
- -
Return on Capital (%)
42.4
15.93
15.49
13.09
9.74
12
- -
11.87
9.22
10.05
34.49
111.56
14.31
-2.92
-3.81
-3.59
-11.8
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'26
Dec'26
ST Debt
135
147
144
LT Borrowings
14
18
17
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3,057
3,057
3,057
Market Capitalization
1,948
1,948
1,881

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'26
Dec'26
Total Current Assets
1,306
1,201
1,085
Cash, Cash Equivalents & STI
866
855
757
Accounts Receivable, Net
58
79
72
Inventories
191
166
149
Total Current Liabilities
298
320
320
Payables & Accruals
- -
- -
- -
ST Debt
135
147
144
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
39.71%
-8.38%
Free Cash Flow
- -
119.38%
-53.55%
Net Income, GAAP
- -
88.51%
-8.67%
Sales/Revenue/Turnover
- -
20.77%
21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
178
146
143
180
646
2025
225
199
204
155
782
2026
206
187
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.01
- -
-0.05
-0.06
2025
-0.02
- -
-0.01
-0.02
- -
2026
-0.04
-0.02
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
- -
- -
- -
0.03
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Winner Medical Co., Ltd. (300888.SZ)
Bionime Corporation (4737.TW)
Comfort Gloves Berhad (2127.KL)
Gerresheimer AG (GXI.DE)
ASO International, Inc. (9340.T)
Golden Valley Development, Inc (GVDI)
Business
Supermax Corporation Berhad Supermax Corporation Berhad is an investment holding company that manufactures, distributes and markets medical gloves and contact lenses. The company produces various types of nitrile, latex and natural rubber gloves, including powder-free examination gloves under brands such as Supermax, Aurelia and Maxter; it also offers personal protective equipment, healthcare products and medical devices. Supermax Corporation Berhad operates eleven manufacturing plants in Malaysia equipped with state-of-the-art machinery and biomass energy systems, alongside a research and development center; it maintains eight own distribution centers in the United States, Brazil, Canada, Germany, the United Kingdom, Hong Kong, Singapore and Japan, and collaborates with over 1,200 independent distributors worldwide. The group exports to more than 165 countries across America, Europe, the Middle East, Asia, Oceania and Africa, serving laboratories, hospitals, pharmacists, doctors, surgeons, dental and scientific markets, with America as its largest revenue contributor. Founded in 1987 by Dato' Seri Stanley Thai and Datin Seri Cheryl Tan as a latex glove trading business in Sungai Buloh, Selangor, Malaysia, it ventured into manufacturing in 1989 and became Malaysia's first own-brand glove manufacturer. In May 2024, Supermax Corporation Berhad acquired the remaining 33% stake in its Canadian subsidiary Supermax Healthcare Canada Inc for RM18.96 million, making it a wholly-owned entity focused on glove marketing and distribution; the group commissioned half the capacity of Phase 1 at its Texas manufacturing plant in January 2025, adding 2.4 billion pieces of annual glove production capacity.